Quantcast

Latest pharmaceutical industry Stories

2014-06-23 08:29:37

FREMONT, Calif., June 23, 2014 /PRNewswire/ -- ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) today announced that ScinoPharm Taiwan Ltd., a manufacturer of potent compound API and finished drug products, has implemented and successfully gone live with the ValGenesis VLMS 3.0 - Validation Lifecycle Management Solution to manage their validation lifecycle processes. Logo - http://photos.prnewswire.com/prnh/20140623/120440...

2014-06-23 08:29:06

Company CEO to present on June 26, 2014, at 10:30am (PDT) JERUSALEM, June 23, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chief Executive Officer, Nadav Kidron, will present at the 2014 BIO International Convention. This year's global event for biotechnology will take place on June 23-26 at the San Diego...

2014-06-23 08:28:39

MILFORD, Mass., June 23, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San Diego. "The research presented continues to expand our understanding of small molecule nucleic acid hybrids (SMNH) and the underlying...

2014-06-23 08:28:11

SHANGHAI, June 23, 2014 /PRNewswire/ -- More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs that ultimately have been designated by the U.S. Food and Drug Administration as breakthrough therapies. The breakthrough designation applies to specific drugs that treat serious medical conditions and show signs of substantial improvements over available therapies, and it enables their speedy...

2014-06-23 08:27:56

DUBLIN, June 23, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Presentation for analysts and investors to be held at 13:00 British Summer Time today The management of Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) has transformed the Company over...

2014-06-23 08:27:20

SOUTH SAN FRANCISCO, Calif., June 23, 2014 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today that they have met all regulatory requirements from Germany's BfArM to initiate a Phase II clinical trial of VPD-737 (serlopitant) in patients with prurigo nodularis. Separately, VPD is also conducting a Phase II clinical trial in the United States evaluating VPD-737 in patients with chronic pruritus. "Prurigo nodularis...

2014-06-23 08:27:17

Company recognized by Foundation of Medical Professionals Alliance in Taiwan BOSTON and TAIPEI, Taiwan, June 23, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named the 2014 Best Performing CRO in Taiwan for its innovative drug development strategies and healthcare industry leadership. PAREXEL received the award in May from the Foundation of Medical Professionals Alliance in Taiwan...

2014-06-21 12:20:21

DALLAS, June 21, 2014 /PRNewswire/ -- MarketOptimizer.org offers "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam" and "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines" market research reports in its store. The pharmaceutical market in Vietnam is set to increase at an impressive 15.4% CAGR to 2020 whereas the Philippines' pharmaceutical industry will grow at 9.4% CAGR to 2020. In Vietnam, the scarcity of...

2014-06-20 23:08:51

In an environment where orphan drug development is on an all-time high and Contract Research Organizations are in demand, orphan reach, who pioneer a unique global patient access solution, has expanded its presence to the US. Audubon, New Jersey (PRWEB) June 20, 2014 orphan reach, the “rare” Contract Research Organization (CRO) focusing on global orphan drug development, has today announced the opening of new offices in New Jersey, USA to target the growing opportunities in the orphan...

2014-06-20 08:23:55

BUENA, N.J., June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions in 2014 to six, with seventeen submissions now pending at the FDA. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO Jason Grenfell-Gardner,...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related